Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Journal of Geriatric Oncology|December 28, 2020
Efficacy and safety of Nivolumab in older patients with pretreated lung cancer: A subgroup analysis of the Galician lung cancer groupDavid Arias Ron, Maria Carmen Areses Manrique, Joaquín Mosquera Martínez, et al.
Expert Opinion on Biological Therapy|May 20, 2026
Arian protocol: a phase iii study of sacituzumab and zimberelimab for the treatment of patients with non-small cell lung cancerMariano Provencio, David Aguiar, Mónica Antoñanzas, et al.
Nature Communications|December 23, 2025
Induction chemo-immunotherapy followed by chemo-radiotherapy and immunotherapy maintenance in stage III NSCLC (APOLO): a phase 2 trialMariano Provencio, Begoña Campos, María Guirado, et al.
Melanoma Research|March 29, 2023
Adjuvant dabrafenib and trametinib for patients with resected BRAF -mutated melanoma: DESCRIBE-AD real-world retrospective observational studyJosé L Manzano, Juan Martin-Liberal, Luis A Fernández-Morales, et al.
JTO Clinical and Research Reports|June 8, 2026
Multidisciplinary Approach to Sexual Dysfunction in Persons With Lung Cancer-Spanish Lung Cancer Group Expert Consensus StatementAylen Vanessa Ospina-Serrano, Constanza Maximiano-Alonso, Pau Guillén-Sentís, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 20, 2025
Title: Characterization of Melanoma of Unknown Primary in the Era of Immunotherapy and Targeted Therapy in Spain: Results from the Prospective Real World Study GEM 1801Pablo Cerezuela-Fuentes, Antonio Piñero-Madrona, Eva Muñoz-Couselo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 10, 2023
Immune checkpoint inhibitor-associated thrombosis in patients with bladder and kidney cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer groupManuel Sánchez Cánovas, David Fernández Garay, Evdochia Adoamnei, et al.
Cancer|July 7, 2026
Real-world effectiveness of chemotherapy regimens after immunotherapy in patients with advanced melanoma in Spain: Results from the GEM1801 studyMiguel-Ángel Berciano-Guerrero, Elisabeth Pérez-Ruiz, Ainara Soria, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 28, 2025
Response rate and long-term survival in patients with advanced melanoma: data from the prospective cohort study gem-1801Enrique Espinosa, Miguel-Ángel Berciano-Guerrero, Eva Muñoz-Couselo, et al.
Pageof 6